David Nemazee

Affiliations: 
Scripps Research Institute, La Jolla, La Jolla, CA, United States 
Google:
"David Nemazee"
Mean distance: 20.52 (cluster 11)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gavin AL, Blane TR, Thinnes TC, et al. (2023) Disease in the Pld4thss/thss Model of Murine Lupus Requires TLR9. Immunohorizons. 7: 577-586
Hurtado J, Flynn C, Lee JH, et al. (2023) Efficient isolation of rare B cells using next-generation antigen barcoding. Frontiers in Cellular and Infection Microbiology. 12: 962945
Okoreeh MK, Kennedy DE, Emmanuel AO, et al. (2022) Asymmetrical forward and reverse developmental trajectories determine molecular programs of B cell antigen receptor editing. Science Immunology. 7: eabm1664
Nahmad AD, Lazzarotto CR, Zelikson N, et al. (2022) In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice. Nature Biotechnology
Cho H, Gonzales-Wartz KK, Huang D, et al. (2021) Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants. Biorxiv : the Preprint Server For Biology
Huang D, Tran JT, Olson A, et al. (2020) Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells. Nature Communications. 11: 5850
Huang D, Abbott RK, Havenar-Daughton C, et al. (2020) B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models. Proceedings of the National Academy of Sciences of the United States of America
Phillips N, Ke E, Nham A, et al. (2020) Prediabetes Induced by a Single Autoimmune B Cell Clone. Frontiers in Immunology. 11: 1073
Rogers TF, Zhao F, Huang D, et al. (2020) Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science (New York, N.Y.)
Wec AZ, Wrapp D, Herbert AS, et al. (2020) Broad neutralization of SARS-related viruses by human monoclonal antibodies. Science (New York, N.Y.)
See more...